Listed

Arcus Biosciences, Inc.

RCUSNYSECIK 1724521HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$33.0m, Q2 FY2026
Operating income−$96.0m, Q2 FY2026
Net income−$91.0m, Q2 FY2026
Arcus Biosciences, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m32.0Revenue, Q3 FY2023, three months to 2023-09-30$32.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure(49.0)Revenue, Q4 FY2023, three months to 2023-12-31−$49.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure10.0Revenue, Q1 FY2024, three months to 2024-03-31$10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure11.0Revenue, Q2 FY2024, three months to 2024-06-30$11.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure7.0Revenue, Q3 FY2024, three months to 2024-09-30$7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure23.0Revenue, Q4 FY2024, three months to 2024-12-31$23.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure8.0Revenue, Q1 FY2025, three months to 2025-03-31$8.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure8.0Revenue, Q2 FY2025, three months to 2025-06-30$8.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure6.0Revenue, Q3 FY2025, three months to 2025-09-30$6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure11.0Revenue, Q4 FY2025, three months to 2025-12-31$11.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure7.0Revenue, Q1 FY2026, three months to 2026-03-31$7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure33.0Revenue, Q2 FY2026, three months to 2026-06-30$33.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Research and development$m82.0Research and development, Q3 FY2023, three months to 2023-09-30$82.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure93.0Research and development, Q4 FY2023, three months to 2023-12-31$93.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure109Research and development, Q1 FY2024, three months to 2024-03-31$109.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure115Research and development, Q2 FY2024, three months to 2024-06-30$115.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure123Research and development, Q3 FY2024, three months to 2024-09-30$123.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure101Research and development, Q4 FY2024, three months to 2024-12-31$101.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure122Research and development, Q1 FY2025, three months to 2025-03-31$122.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure139Research and development, Q2 FY2025, three months to 2025-06-30$139.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure141Research and development, Q3 FY2025, three months to 2025-09-30$141.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure121Research and development, Q4 FY2025, three months to 2025-12-31$121.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure122Research and development, Q1 FY2026, three months to 2026-03-31$122.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure113Research and development, Q2 FY2026, three months to 2026-06-30$113.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Operating income$m(80.0)Operating income, Q3 FY2023, three months to 2023-09-30−$80.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure(91.0)Operating income, Q4 FY2023, three months to 2023-12-31−$91.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(16.0)Operating income, Q1 FY2024, three months to 2024-03-31−$16.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure(106)Operating income, Q2 FY2024, three months to 2024-06-30−$106.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure(105)Operating income, Q3 FY2024, three months to 2024-09-30−$105.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure(103)Operating income, Q4 FY2024, three months to 2024-12-31−$103.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(122)Operating income, Q1 FY2025, three months to 2025-03-31−$122.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure(8.0)Operating income, Q2 FY2025, three months to 2025-06-30−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure(142)Operating income, Q3 FY2025, three months to 2025-09-30−$142.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure(114)Operating income, Q4 FY2025, three months to 2025-12-31−$114.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(134)Operating income, Q1 FY2026, three months to 2026-03-31−$134.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure(96.0)Operating income, Q2 FY2026, three months to 2026-06-30−$96.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Interest expense$m1.0Interest expense, Q3 FY2023, three months to 2023-09-30$1.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2024, three months to 2024-03-31$1.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure1.0Interest expense, Q3 FY2024, three months to 2024-09-30$1.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure2.0Interest expense, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure1.0Interest expense, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure2.0Interest expense, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure3.0Interest expense, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure2.0Interest expense, Q4 FY2025, three months to 2025-12-31$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure3.0Interest expense, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure3.0Interest expense, Q2 FY2026, three months to 2026-06-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Income tax$m2.0Income tax, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure1.0Income tax, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure1.0Income tax, Q4 FY2024, three months to 2024-12-31$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Net income$m(71.0)Net income, Q3 FY2023, three months to 2023-09-30−$71.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure(81.0)Net income, Q4 FY2023, three months to 2023-12-31−$81.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(4.0)Net income, Q1 FY2024, three months to 2024-03-31−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure(93.0)Net income, Q2 FY2024, three months to 2024-06-30−$93.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure(92.0)Net income, Q3 FY2024, three months to 2024-09-30−$92.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure(94.0)Net income, Q4 FY2024, three months to 2024-12-31−$94.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(112)Net income, Q1 FY2025, three months to 2025-03-31−$112.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure0.0Net income, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure(135)Net income, Q3 FY2025, three months to 2025-09-30−$135.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure(106)Net income, Q4 FY2025, three months to 2025-12-31−$106.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(128)Net income, Q1 FY2026, three months to 2026-03-31−$128.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure(91.0)Net income, Q2 FY2026, three months to 2026-06-30−$91.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Diluted EPS$ per share(0.94)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figurenot reported(0.05)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure(1.02)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure(1.00)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figurenot reported(1.14)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure0.00Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure(1.27)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figurenot reported(1.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure(0.72)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Basic EPS$ per share(0.94)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figurenot reported(0.05)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure(1.02)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure(1.00)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figurenot reported(1.14)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure0.00Basic EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure(1.27)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figurenot reported(1.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure(0.72)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure

Balance sheet

Cash and equivalents$150.0m, Q2 FY2026
Long-term debt$101.0m, Q2 FY2026
Shareholders' equity$464.0m, Q2 FY2026
Arcus Biosciences, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m184Cash and equivalents, Q3 FY2023, at 2023-09-30$184.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure127Cash and equivalents, FY2023, at 2023-12-31$127.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-25, accession 0001724521-25-000040.Report this figure185Cash and equivalents, Q1 FY2024, at 2024-03-31$185.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure156Cash and equivalents, Q2 FY2024, at 2024-06-30$156.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure201Cash and equivalents, Q3 FY2024, at 2024-09-30$201.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure150Cash and equivalents, FY2024, at 2024-12-31$150.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001724521-26-000009.Report this figure192Cash and equivalents, Q1 FY2025, at 2025-03-31$192.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure248Cash and equivalents, Q2 FY2025, at 2025-06-30$248.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure238Cash and equivalents, Q3 FY2025, at 2025-09-30$238.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure222Cash and equivalents, FY2025, at 2025-12-31$222.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure201Cash and equivalents, Q1 FY2026, at 2026-03-31$201.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure150Cash and equivalents, Q2 FY2026, at 2026-06-30$150.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Current assets$m882Current assets, Q3 FY2023, at 2023-09-30$882.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001724521-23-000021.Report this figure831Current assets, FY2023, at 2023-12-31$831.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0001724521-25-000040.Report this figure1,064Current assets, Q1 FY2024, at 2024-03-31$1.06bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001724521-24-000092.Report this figure1,022Current assets, Q2 FY2024, at 2024-06-30$1.02bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001724521-24-000138.Report this figure1,127Current assets, Q3 FY2024, at 2024-09-30$1.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure1,016Current assets, FY2024, at 2024-12-31$1.02bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001724521-26-000009.Report this figure1,031Current assets, Q1 FY2025, at 2025-03-31$1.03bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure946Current assets, Q2 FY2025, at 2025-06-30$946.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure857Current assets, Q3 FY2025, at 2025-09-30$857.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure1,007Current assets, FY2025, at 2025-12-31$1.01bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure844Current assets, Q1 FY2026, at 2026-03-31$844.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure756Current assets, Q2 FY2026, at 2026-06-30$756.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Total assets$m1,191Total assets, Q3 FY2023, at 2023-09-30$1.19bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001724521-23-000021.Report this figure1,095Total assets, FY2023, at 2023-12-31$1.09bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0001724521-25-000040.Report this figure1,293Total assets, Q1 FY2024, at 2024-03-31$1.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001724521-24-000092.Report this figure1,186Total assets, Q2 FY2024, at 2024-06-30$1.19bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001724521-24-000138.Report this figure1,252Total assets, Q3 FY2024, at 2024-09-30$1.25bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure1,150Total assets, FY2024, at 2024-12-31$1.15bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001724521-26-000009.Report this figure1,156Total assets, Q1 FY2025, at 2025-03-31$1.16bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure1,075Total assets, Q2 FY2025, at 2025-06-30$1.07bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure974Total assets, Q3 FY2025, at 2025-09-30$974.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure1,139Total assets, FY2025, at 2025-12-31$1.14bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure997Total assets, Q1 FY2026, at 2026-03-31$997.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure924Total assets, Q2 FY2026, at 2026-06-30$924.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Current liabilities$m200Current liabilities, Q3 FY2023, at 2023-09-30$200.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001724521-23-000021.Report this figure184Current liabilities, FY2023, at 2023-12-31$184.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0001724521-25-000040.Report this figure204Current liabilities, Q1 FY2024, at 2024-03-31$204.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001724521-24-000092.Report this figure199Current liabilities, Q2 FY2024, at 2024-06-30$199.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001724521-24-000138.Report this figure215Current liabilities, Q3 FY2024, at 2024-09-30$215.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure226Current liabilities, FY2024, at 2024-12-31$226.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001724521-26-000009.Report this figure192Current liabilities, Q1 FY2025, at 2025-03-31$192.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure210Current liabilities, Q2 FY2025, at 2025-06-30$210.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure235Current liabilities, Q3 FY2025, at 2025-09-30$235.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure231Current liabilities, FY2025, at 2025-12-31$231.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure209Current liabilities, Q1 FY2026, at 2026-03-31$209.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure198Current liabilities, Q2 FY2026, at 2026-06-30$198.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Total liabilities$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Long-term debt$mnot reported0.0Long-term debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-02-25, accession 0001724521-25-000040.Report this figurenot reportednot reported47.0Long-term debt, Q3 FY2024, at 2024-09-30$47.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure48.0Long-term debt, FY2024, at 2024-12-31$48.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-25, accession 0001724521-26-000009.Report this figure48.0Long-term debt, Q1 FY2025, at 2025-03-31$48.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure97.0Long-term debt, Q2 FY2025, at 2025-06-30$97.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure98.0Long-term debt, Q3 FY2025, at 2025-09-30$98.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure99.0Long-term debt, FY2025, at 2025-12-31$99.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure100Long-term debt, Q1 FY2026, at 2026-03-31$100.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure101Long-term debt, Q2 FY2026, at 2026-06-30$101.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure
Shareholders' equity$m520Shareholders' equity, Q3 FY2023, at 2023-09-30$520.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure462Shareholders' equity, FY2023, at 2023-12-31$462.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001724521-26-000009.Report this figure707Shareholders' equity, Q1 FY2024, at 2024-03-31$707.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure635Shareholders' equity, Q2 FY2024, at 2024-06-30$635.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure565Shareholders' equity, Q3 FY2024, at 2024-09-30$565.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure485Shareholders' equity, FY2024, at 2024-12-31$485.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure531Shareholders' equity, Q1 FY2025, at 2025-03-31$531.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure549Shareholders' equity, Q2 FY2025, at 2025-06-30$549.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure436Shareholders' equity, Q3 FY2025, at 2025-09-30$436.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure631Shareholders' equity, FY2025, at 2025-12-31$631.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure524Shareholders' equity, Q1 FY2026, at 2026-03-31$524.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure464Shareholders' equity, Q2 FY2026, at 2026-06-30$464.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure

Cash flow

Operating cash flow−$119.0m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Arcus Biosciences, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(63.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$63.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001724521-24-000160. Derived: 9-month figure less the 6-month figure.Report this figure(88.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$88.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(2.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure(94.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$94.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001724521-25-000101. Derived: 6-month figure less the 3-month figure.Report this figure26.0Operating cash flow, Q3 FY2024, three months to 2024-09-30$26.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001724521-25-000116. Derived: 9-month figure less the 6-month figure.Report this figure(100)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$100.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(132)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$132.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure(133)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$133.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001724521-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure(97.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$97.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-28, accession 0001724521-25-000116. Derived: 9-month figure less the 6-month figure.Report this figure(120)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$120.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(138)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$138.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure(119)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$119.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001724521-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m10.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$10.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001724521-24-000160. Derived: 9-month figure less the 6-month figure.Report this figure6.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$6.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure4.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$4.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001724521-25-000101. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001724521-25-000116. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001724521-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-28, accession 0001724521-25-000116. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001724521-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001724521-26-000044. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)126.10m, Q2 FY2026
Arcus Biosciences, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares72.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3072,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001724521-23-000021.Report this figure73.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3173,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001724521-24-000092.Report this figure73.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3073,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001724521-24-000138.Report this figure74.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3074,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001724521-24-000160.Report this figure86.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3186,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001724521-25-000063.Report this figure91.1Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3091,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001724521-25-000101.Report this figure91.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3091,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure98.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3198,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure107Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30106,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure107Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30106,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-28, accession 0001724521-25-000116.Report this figure125Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31125,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001724521-26-000034.Report this figure126Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30126,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure

Shares outstanding: 127.33mShares outstanding, period not labelled, at 2026-07-30127,333,376 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001724521-26-000044.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.